Literature DB >> 1249423

Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF).

M R Daha, D T Fearon, K F Austen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1249423

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  9 in total

Review 1.  Factor I and factor H deficiency in renal diseases: similar defects in the fluid phase have a different outcome at the surface of the glomerular basement membrane.

Authors:  Peter F Zipfel; Richard J H Smith; Christine Skerka
Journal:  Nephrol Dial Transplant       Date:  2008-12-04       Impact factor: 5.992

2.  Complement activation in factor D-deficient mice.

Authors:  Y Xu; M Ma; G C Ippolito; H W Schroeder; M C Carroll; J E Volanakis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

3.  Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.

Authors:  J G Sissons; J Liebowitch; N Amos; D K Peters
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

4.  Murine monoclonal anti-Ba antibody that enhances haemolytic activity of factor B.

Authors:  E Tanaka; K Hong; T Kinoshita; Y Takata; H Kozono; J Takeda; A Yoden; K Inoue
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

5.  Modulation of the formation of the human amplification C3 convertase of complement by polycations.

Authors:  F Maillet; M D Kazatchkine
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

6.  Formation in the presence of C3 nephritic factor (C3NeF) of an alternative pathway C3 convertase containing uncleaved B.

Authors:  M R Daha; D T Fearon; K F Austen
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

7.  Control of the amplification convertase of complement by the plasma protein beta1H.

Authors:  J M Weiler; M R Daha; K F Austen; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

8.  Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.

Authors:  D T Fearon; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

9.  Mechanism of action of factor D of the alternative complement pathway.

Authors:  P H Lesavre; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.